King Saud Medical City (KSMC), through the Heart Health Center, has achieved a groundbreaking medical milestone with the use of Supersaturated Oxygen (SSO2) Therapy to treat a patient experiencing an acute heart attack in the anterior left artery. This achievement marks the first time it has been accomplished in the Middle East and North Africa.
KSMC explained that this innovative technology aids in protecting the heart muscle cells from damage following an acute heart attack. It has been scientifically validated and is approved by both the Saudi Food and Drug Authority (SFDA) and the American Food and Drug Administration (FDA).
KSMC emphasized that the patient is currently in good health and will be discharged shortly.
Source: Saudi Press Agency